Premium
Chapter 3: Clinical Review, Therapeutic Drug Monitoring and Adverse Drug Reaction Management
Author(s) -
George Taylor,
Anne Leversha,
Christopher Archer,
Camille Boland,
Michael J. Dooley,
Peter Fowler,
Sharon Gordon-Croal,
Jay Fitch,
Sally Marotti,
Amy McKenzie,
Duncan McKenzie,
Natalie Collard,
Nicki Burridge,
Karen O'Leary,
Cameron Randall,
Amber Roberts,
Suzette Seaton
Publication year - 2013
Publication title -
journal of pharmacy practice and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 22
eISSN - 2055-2335
pISSN - 1445-937X
DOI - 10.1002/j.2055-2335.2013.tb00897.x
Subject(s) - medicine , drug , citation , adverse drug reaction , pharmacy , drug reaction , pharmacology , family medicine , library science , computer science
Clinical review, therapeutic drug monitoring (TDM) and adverse drug reaction (ADR) management contribute to the quality use of medicines by ensuring safe and appropriate dosage and administration of medicines, improving response to therapy and minimising medicinesrelated problems. Clinical review, TDM and ADR management commence when a patient presents or is admitted to a health service organisation and continue as routine activities throughout the episode of care in conjunction with assessment of current medication management and other clinical pharmacy activities.